CRISPR Therapeutics AG financial data

Symbol
CRSP on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
Baarerstrasse 14, Zug, Switzerland
State of incorporation
Switzerland
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.67K % +22%
Debt-to-equity 18.5 % -9.76%
Return On Equity -13.9 % +37.6%
Return On Assets -11.7 % +36.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.2M shares +7.25%
Common Stock, Shares, Outstanding 85M shares +7.15%
Entity Public Float 4.1B USD -4.65%
Common Stock, Value, Issued 2.67M USD +7.72%
Weighted Average Number of Shares Outstanding, Basic 84.9M shares +7.37%
Weighted Average Number of Shares Outstanding, Diluted 84.9M shares +7.37%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 517K USD -99.3%
Research and Development Expense 342M USD -18.9%
General and Administrative Expense 72.2M USD -19.4%
Operating Income (Loss) -355M USD +25.1%
Nonoperating Income (Expense) 91.5M USD +83.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -263M USD +37.9%
Income Tax Expense (Benefit) 2.66M USD +39.4%
Net Income (Loss) Attributable to Parent -266M USD +36.1%
Earnings Per Share, Basic -3.21 USD/shares +39.3%
Earnings Per Share, Diluted -3.21 USD/shares +39.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 484M USD +8.92%
Marketable Securities, Current 1.52B USD +14.6%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 2.01B USD +8.11%
Property, Plant and Equipment, Net 143M USD -10.1%
Operating Lease, Right-of-Use Asset 149M USD -6.79%
Other Assets, Noncurrent 15.1M USD +596%
Assets 2.34B USD +6.5%
Accounts Payable, Current 9.45M USD -65.7%
Employee-related Liabilities, Current 14.4M USD +14.2%
Accrued Liabilities, Current 91.9M USD +2.28%
Contract with Customer, Liability, Current 4.76M USD
Liabilities, Current 128M USD -3.78%
Contract with Customer, Liability, Noncurrent 12.6M USD +2.11%
Operating Lease, Liability, Noncurrent 215M USD -6.73%
Other Liabilities, Noncurrent 3.65M USD -33.5%
Liabilities 359M USD -5.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.88M USD +67.7%
Retained Earnings (Accumulated Deficit) -1.24B USD -27.2%
Stockholders' Equity Attributable to Parent 1.98B USD +9.08%
Liabilities and Equity 2.34B USD +6.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 110M USD +1147%
Net Cash Provided by (Used in) Financing Activities 306M USD +5561%
Net Cash Provided by (Used in) Investing Activities -97.8M USD -183%
Common Stock, Shares Authorized 132M shares
Common Stock, Shares, Issued 85.2M shares +7.12%
Common Stock, Par or Stated Value Per Share 0.03 CHF/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 318M USD +141%
Deferred Tax Assets, Valuation Allowance 228M USD +14.8%
Deferred Tax Assets, Gross 308M USD +9.43%
Operating Lease, Liability 239M USD -2.21%
Depreciation 19.4M USD -6.73%
Payments to Acquire Property, Plant, and Equipment 721K USD -76.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -260M USD +35.8%
Lessee, Operating Lease, Liability, to be Paid 323M USD -5.17%
Property, Plant and Equipment, Gross 206M USD +1.53%
Operating Lease, Liability, Current 16.5M USD +10.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 28.8M USD +8.67%
Lessee, Operating Lease, Liability, to be Paid, Year One 28.7M USD -1.94%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 84M USD -12.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 29.4M USD +12%
Deferred Tax Assets, Operating Loss Carryforwards 133M USD +12.6%
Unrecognized Tax Benefits 44.1M USD +27.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 28.7M USD +7.19%
Depreciation, Depletion and Amortization 4.83M USD -4.32%
Deferred Tax Assets, Net of Valuation Allowance 80.2M USD -3.38%
Share-based Payment Arrangement, Expense 81.5M USD -9.47%